Abstract
Here we report the first crystal structure of a high-contrast genetically encoded circularly permuted green fluorescent protein (cpGFP)-based Ca2+ sensor, Case16, in the presence of a low Ca2+ concentration. The structure reveals the positioning of the chromophore within Case16 at the first stage of the Ca2+-dependent response when only two out of four Ca2+-binding pockets of calmodulin (CaM) are occupied with Ca2+ ions. In such a “half Ca2+-bound state”, Case16 is characterized by an incomplete interaction between its CaM-/M13-domains. We also report the crystal structure of the related Ca2+ sensor Case12 at saturating Ca2+ concentration. Based on this structure, we postulate that cpGFP-based Ca2+ sensors can form non-functional homodimers where the CaM-domain of one sensor molecule binds symmetrically to the M13-peptide of the partner sensor molecule. Case12 and Case16 behavior upon addition of high concentrations of free CaM or M13-peptide reveals that the latter effectively blocks the fluorescent response of the sensor. We speculate that the demonstrated intermolecular interaction with endogenous substrates and homodimerization can impede proper functioning of this type of Ca2+ sensors in living cells.
Keywords: circularly permuted green fluorescent protein, genetically encoded, fluorescent calcium indicator protein, crystal structure, calcium sensor
1. Introduction
The development of effective fluorescent Ca2+ indicator proteins (FCIPs) is a challenge for a number of laboratories working with fluorescent proteins (FPs). Attempts to generate a sensor that combines high fluorescence brightness, fast and high-contrast response, low pH-dependency, does not interact with intracellular proteins, reliably targets specific cellular compartments, has high expression levels, and has the ability to reliably monitor Ca2+ changes in various systems (including neurons in vivo and ex vivo) has resulted in sequential improvements of FCIPs in recent years. However, a sensor combining all the properties mentioned above still has not been developed.
The most popular FCIP design uses distance and dipole orientation changes between the donor and acceptor FP chromophores mediated by Ca2+-dependent conformational changes of fused Ca2+-sensitive domains (such as calmodulin (CaM) [1–8] or troponin C (TnC) [9–11]), leading to more or less pronounced changes in the Förster Resonance Energy Transfer (FRET) efficiency. An alternative approach is to insert the single circularly permuted green fluorescent protein (cpGFP) between CaM and M13-peptide (fragment of myosin light-chain kinase). The circular permutation of GFP-like proteins allows for the fusion of sensing domains in the close proximity to the chromophore. Thus Ca2+-dependent conformational changes can influence the chromophore environment and the fluorescent properties of the sensor directly. A number of FCIPs of the latter type, employing cpGFPs at positions 145–148 (such as Pericams [5] and GCaMPs [2,4,6,8]), have been previously reported. The cpGFP-based FCIPs with the highest contrast described to date are 12- and 16-fold contrast Ca2+ sensors Case12 and Case16 [7]. They are characterized by high brightness, fast maturation at 37 °C and pronounced fluorescence changes in response to hundreds of nanomoles of Ca2+. Despite the fact that cpGFP-based FCIPs have a mechanism essentially identical to those of so-called “photo-activatable” FPs (i.e., the deprotonation of the neutral GFP chromophore), the contrast of the best FCIPs developed to date—GCaMP2 [6], GCaMP3 [8], Case12 and Case16 [7]—is only 5–16-fold, while photoactivatable FPs can reach 100–400 fold contrast levels [12,13]. Thus it is reasonable to assume that the fluorescent response of cpGFP-based FCIPs can still be improved.
Progress in the generation of improved FCIP variants has been limited by the absence of structural data describing cpGFP alone and fused with Ca2+-sensitive domains. In most of cpGFP-based FCIPs the permutation point (i.e., the breakpoint of the polypeptide chain) is located between amino acids 145 and 148 in the native sequence. However, until recently the real spatial positioning of the chromophore environment as well as relative positioning of the linkers, cpGFP fluorescent “core” and fused Ca2+-sensitive domains remained unclear. Thus the structural information about cpGFP-based Ca2+ sensors is absolutely crucial for their further improvement as well as for development of cpGFP-based sensors for analytes other than Ca2+.
Recently two research groups independently published the crystal structure of the Ca2+ sensor GCaMP2 in its Ca2+-saturated form [14,15]. These data revealed the relative arrangement of domains and a number of key features of the chromophore environment and allowed to enhance brightness and dynamic range of GCaMP2 using site-specific mutagenesis by decreasing solvent access to the chromophore. However, understanding the molecular details of the mechanism of the sensor response at low Ca2+ concentrations would be useful in the rational design of enhanced sensor variants.
Here we report the crystal structure of the high-contrast GCaMP-like (see Supplementary Figure 1 for protein sequence alignment) Ca2+ sensor Case16 [7] in the presence of low Ca2+ concentration. At this intermediate stage of Ca2+-dependent response Case16 is characterized by incomplete interaction of CaM with its target M13-peptide and its chromophore environment differs significantly from that of GCaMP2 in its Ca2+-saturated form reported earlier [14,15]. We also resolved the structure of the related Ca2+ sensor variant Case12 [7] at high Ca2+ concentration. This structure confirms that at high concentrations GCaMP-like Ca2+ sensors form non-functional homodimers that is consistent with the previously reported data for GCaMP2 [14,15]. Taken together, our data contribute to the structural understanding of cpGFP-based Ca2+ sensors and could enable the development of improved genetically encoded sensor variants for Ca2+ and other analytes.
2. Experimental Section
2.1. Cloning and Protein Purification
The DNA coding sequences of Case12 and Case16 sensors were amplified by PCR from the corresponding pQE30-based expression vectors (Qiagen) as described in [7]. For amplification of cDNA inserts a “sticky-end” PCR [17] was performed using a pair of 5′-end primers complementary to M13-peptide (5′-CTCACGTCGTAAGTGGAA-3′; 5′-GATCCTCACGTCGTAAGTGGAA-3′) and a pair of 3′-end primers complementary to CaM (5′-GGCCGCATTATTTTGCAGTCATCATCT GTACG-3′; 5′-GCATTATTTTGCAGTCATCATCTGTACG-3′) containing Bam HI and Not I restriction sites, respectively. To obtain the final expression vectors the coding sequence of the corresponding sensor variant was cloned using BamHI/NotI restrictions sites into reengineered expression vector pET41a(+) (Merck Biosciences) where the GST-tag has been deleted and the thrombin site was replaced by N-terminal fusion partner containing a His6-tag followed by a S-tag and a PreScission protease cleavage site [18].
Each of the plasmids coding either Case12 or Case16 sensor variant was transformed into BL21(DE3) Tuner E. coli cells. The bacteria were grown in TB mod cultivation medium containing 0.1 M MOPS buffer and 30 mg/L kanamycin to an OD600 = 0.8. For the induction of protein expression 0.1 mM IPTG was added and cells were incubated overnight at 20 °C. The cell pellets were harvested by centrifugation, resuspended in IMAC buffer A (50 mM Na-phosphate, 300 mM NaCl, 20 mM imidazole, pH 8.0) and lysed with a high pressure homogenizer (Avestin). The filtered lysate containing soluble proteins was loaded on a 5 mL His-Trap IMAC column mounted on an AEKTA Explorer 100 chromatography system (GE Healthcare). After extensive washing of the column with IMAC buffer A, 500 U of PreScission protease (GE Healthcare) were loaded onto the His-Trap column for direct cleavage of the N-terminal His6 S-tag fragment from the fusion protein. After further incubation at 4 °C during 10 h the cleaved Case12 and Case16 sensor proteins were eluted from the column with IMAC buffer A. Pooled fractions were subjected to size-exclusion chromatography that was performed on a Superdex75 XK16/60 column (GE Healthcare) using TBS running buffer (50 mM Tris-HCl, 150 mM NaCl, pH 7.4). The fractions containing purified sensor proteins were pooled and aliquots were snap-frozen at −80 °C. LC-MS analysis confirmed the correct and expected mass of the proteins with the overhanging amino acids Gly-Pro-Gly-Ser at the N-terminus derived from the PreScission protease site and the BamHI restriction site as described earlier [18].
2.2. Crystallization Conditions
For “crystallization condition A” (low Ca2+ concentration) crystallization was performed in a hanging drop, vapor diffusion set-up (Case16 structure A). Protein stock solution: 4.1 mg/mL Case16, 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 10 mM DTT. Reservoir solution: 50 mM imidazole, 1.9 M Na2malonate, pH 6.4. Drop: 3 μL protein solution and 1 μL reservoir solution. The reservoir volume was 0.5 mL. Incubation was performed at 20 °C. For “crystallization condition B” (high Ca2+ concentration) crystallization was performed in a hanging drop, vapor diffusion set-up (Case12 structure B). Protein stock solution: 7.6 mg/mL Case12, 50 mM Tris-HCl, pH 7.4, 150 mM NaCl. Seed stock solution: 200 mM CaCl2, 20% PEG-3350. Reservoir solution: 100 mM Tris-HCl, pH = 5.5, 100 mM (NH4)2SO4, 21% PEG-3350. Drop: 1 μL protein solution, 1 μL reservoir solution and 1 μL seed stock solution. The reservoir volume was 0.5 mL. Incubation was performed at 20 °C.
2.3. Data Collection and Analysis
The data set of Case16 crystals (“crystallization condition A”) was collected to a resolution of 2.35 Å at the PXII (X10SA) beam line at the Swiss Light Source (SLS) in Villigen, Switzerland. This beam line was equipped with a MARCCD detector and cryo-stream to keep the crystals at 100 K. Images were collected with 0.5° oscillation each and a crystal-to-detector distance of 200 mm. The dataset of the Case12 crystal (“crystallization condition B”) was collected to a resolution of 2.6 Å on a Rigaku FRE generator equipped with a MAR Image plate and an Oxford Cryo-system. Raw diffraction data were processed and scaled with XDS/Xscale [19] within the APRV program package [20]. The data collection statistics can be found in Table 1.
Table 1.
Case16 structure A | Case12 structure B | |
---|---|---|
Data collectiona | ||
X-ray source | Swiss Light Source (PX2) | Rigaku FRE |
Detector type | CCDCHESS-3072-SLS-PX2 225 mm | MAR345-2300-PSU-345 mm |
Wavelength (Å) | 0.99990 | 1.54179 |
Space group | P21212 | P21 |
Cell dimensions | ||
a, b. c (Å) | 92.5, 106.9, 43.3 | 46.4, 101.6, 82.2 |
α, β, γ (deg) | 90.0, 90.0, 90.0 | 90.0, 91.5, 90.0 |
Resolution | 92.50–2.35 (2.54–2.35) | 100.00–2.60 (2.71–2.60) |
Rsym (%) | 8.8 (57.7) | 10.1 (51.7) |
I/sig(I) (%) | 14.4 (3.3) | 12.0 (2.8) |
Completeness (%) | 98.7 (90.1) | 99.8 (99.8) |
Completeness (highest shell I/sig(I) > 3)(%) | 38.7 | 31.3 |
Redundancy (%) | 6.9 (6.9) | 3.7 (3.7) |
Number of observed reflections | 128,528 | 87,933 |
Number of unique Reflections | 18,555 | 23,464 |
Wilson Bfactor (Å2) | 49.6 | 41.9 |
Refinementb | ||
Resolution range (Å) | 70.01–2.35 (2.411–2.35) | 50.83–2.60 (2.667–2.60) |
Completeness (%) | 99.94 (100.0) | 99.83 (99.77) |
Number of reflections | 17.624 (1,278) | 22.288 (1,626) |
R value | 0.1995 | 0.245 |
R free | 0.2730 | 0.316 |
R free test set size (%) | 5.0 | 5.0 |
R value | 0.217 | 0.340 |
R free | 0.348 | 0.453 |
Number of atoms | 3169 | 6434 |
Mean B (Å2) | 51.129 | 22.432 |
PDB ID | 3077 | 3078 |
Estimated coordinate error based on | ||
R value | 0.380 | 0.939 |
R free | 0.278 | 0.450 |
ML | 0.212 | 0.376 |
B ML (Å2) | 16.931 | 24.100 |
Bond lengths (Å) | 0.022 | 0.015 |
Bond angles (deg) | 1.978° | 1.726° |
Highest resolution shell is shown in parenthesis.
No sigma cutoffs.
2.4. Structure Determination and Refinement
Case16 structure A (at low Ca2+ concentration) was solved using the molecular replacement program MOLREP [21] with GFP as a search model. The distorted CaM was traced by placing polyalanine α-helices into the residual electron density, followed by several cycles of refinement and gradually completing the model. For Case12 structure B (at high Ca2+ concentration) cpFP and CaM were localized independently by molecular replacement. Model building was performed using the COOT program [22]. The model was refined by the program REFMAC [23] which is part of the CCP4 suite (Collaborative Computational Project 1994). The refinement statistics is given in the Table 1. Figures were made using the program PYMOL (DeLano Scientific LLC, Palo Alto, CA, USA).
2.5. Characterization of the Oligomerization State of Ca2+ Sensors with Multi Angle Light Scattering (MALS)
Case12 and Case16 sensors were analyzed at concentrations of 4 mg/mL or 16 mg/mL. For higher concentrations the protein samples were concentrated using an Amicon Ultra 4 10kDa MWCO membrane (Millipore). Solutions containing 100 mM EGTA or 100 mM CaCl2 were added to a final concentration of 5 mM resulting in Ca2+-free or Ca2+-saturated states of the sensor, respectively. After further incubation for 1 h, 200 μL of the protein solution were loaded onto a Superdex 200 HR30/10 column mounted on an AEKTA Purifier 100 chromatography system. The running buffer contained 50 mM Tris-HCl, 300 mM NaCl, pH 7.4 and either 5 mM EGTA or 1 mM CaCl2, depending on the sensor form to be analyzed. The size exclusion column was connected serially with a MiniDawn Tri-Star multi-angle light scattering detector (Wyatt Technologies) and RI-71 refractive index detector. This set-up allowed a direct on-line determination of the oligomerization state (i.e., monomer vs. dimer) of the eluted protein.
2.6. Testing the Sensitivity of Case12 and Case16 Sensors to Free CaM or M13-peptide
Each of the three proteins Case 12, Case 16 and bovine CaM (Calbiochem) was incubated in TBS buffer together with 10 mM EGTA and subsequently dialyzed extensively against pure TBS to obtain the Ca2+-free form of the proteins excluding the Ca2+-chelating agent EGTA. M13-peptide (Ac-SSRRKWQKTGHAVRAIGRLSS-NH2; Biosyntan GmbH) was dissolved in PBS. The final concentrations for different components were 10 μM for both Ca2+ sensor proteins, 50 μM for CaM and 200 μM for M13-peptide. The solutions containing CaM or M13 peptide were diluted serially in 2-fold steps into a 384 low volume black multi-well plate (Greiner), 20 μL in each well. An equal volume of the samples, containing either Case 12 or Case 16 was then added. The final concentration of the sensors was fixed at 5 μM and ranged between 0.2–25 μM for CaM and 0.8–100 μM for M13-peptide, respectively. Ca2+ sensors diluted in pure TBS served as “zero value” and all samples were mixed in triplicates. The fluorescence intensity of the samples was measured using an Envision multilabel plate reader (Perkin Elmer) with the excitation wavelength set at 485 nm and the emission wavelength set at 535 nm. The first measurement cycle was performed with the proteins in absence of Ca2+, giving the “low value (L)”. The second measurement cycle was performed after addition of 4 μL 0.1 M CaCl2 (final concentration 10 mM) and incubation for 15 min at room temperature resulting in the “high value (H)”.
3. Results and Discussion
3.1. Structure of Case16 Sensor Freezed in Its “half Ca2+-bound” State
Earlier we described circularly permuted GFP (cpGFP)-based Ca2+ sensors Case12 and Case16 with superior dynamic ranges of up to 12-fold and 16.5-fold increase in green fluorescence between Ca2+-free and Ca2+-saturated forms [7]. The overall structure of these sensors is a monomer consisting of cpGFP “core” in its typical β-barrel shape inserted between an M13-peptide and CaM-domains.
In the present study Case16 sensor protein was crystallized at a low Ca2+ concentration (see Experimental Section, “crystallization condition A” and Table 1). No Ca2+ was added in the protein stock solution and in the reservoir solution. At the same time, no special Ca2+-free reagents or Ca2+ purification steps were used. Therefore the starting solution for crystallization contained background levels of Ca2+ coming from Na2malonate, NaCl and other reagents. It was reported earlier that adding an excess of a Ca2+ chelator (EGTA) did not yield a Ca2+-free structure and still produced crystals at dimeric Ca2+-bound form [15]. However, under “crystallization condition A” we were able to freeze the Case16 sensor in its “half Ca2+-bound state”. The crystal structure of Case16 (Case16 structure A, refined to 2.35 Å resolution) formed a monomer in the asymmetric unit (Figure 1a).
It was reported earlier that CaM possesses 4 EF-hand Ca2+-binding sites with differing Ca2+-binding affinities [24,25]. While the high-affinity C-terminal pair of sites is occupied at relatively low Ca2+ concentrations (below 500 nM), the N-terminal pair is occupied only at higher Ca2+ concentrations (above 500 nM). Therefore the initial Ca2+-dependent fluorescent response of the sensor in 100–500 nM range of Ca2+ can be determined by the structural rearrangements in response to filling of the first two high-affinity Ca2+-binding pockets of the C-terminal part of CaM. In agreement with this data, the structure A of Case16 reveals that only the two C-terminal Ca2+-binding sites of CaM are occupied with Ca2+ whereas both of its N-terminal sites are Ca2+-free. It is assumed that this structure of Case16 corresponds to the first stage of the fluorescent response of the sensor to low (below 500 nM) Ca2+ concentrations.
It is also important to note that Case16 structure A demonstrates an unexpected binding mode of CaM and M13-peptide. The CaM domain is in its open extended conformation and the M13-peptide was bound only to the C-terminal lobe of CaM (Figure 1b). Most likely, this particular CaM-M13 binding mode is mediated by the two complexed Ca2+ ions and an aromatic residue of the M13-peptide (Trp9) penetrating into a deep pocket of the C-terminal lobe of CaM. The N- and C-terminal CaM lobes of the previously reported structure [26] (PDB Access code = 1 CDL) align with an rmsd (root mean square deviation) of 4.60 Å (72 C-alpha atoms) and 1.00 Å (67 C-alpha atoms), respectively. This shows that the structure of the C-teminal lobe aligns well, while the N-terminal lobe of CaM shows a completely different arrangement, not only due to the open conformation, but also due to conformational changes induced by the missing Ca2+ ions.
In the wild type Aequorea victoria GFP (wtGFP) amino acid residues 143–152 form the 7th β-strand of the β-barrel. In Case16 the GFP moiety is circularly permuted leading to a break between positions 145 and 148. This break shortens the 7th β-strand in comparison to wtGFP and the new N- and C-termini of cpGFP are connected to M13- and CaM-domains of the sensor, respectively (a.a. numbering corresponds to wtGFP, see Supplementary Figure 1). Local rearrangements that are caused by the binding of the M13 peptide to CaM can influence the stability of this β-strand and thus may alter the fluorescent properties of the sensor molecule. Based on the resolved structure of Case16 we propose that binding of the M13-peptide to the C-terminal lobe of CaM in the context of the sensor stabilizes the arrangement of the 7th β-strand of GFP in its natural position. In other words, amino acid residues corresponding to positions 148–150 of the GFP should protrude out of the β-barrel as was predicted for the reconstructed Ca2+-free structure of GCaMP2 (PDB Access code = 3EKJ) [15]. The N-terminal lobe of CaM is in close contact with cpGFP and should further “clasp” and stabilize the 7th strand of GFP β-barrel (Figure 1). Therefore, the most likely explanation for the markedly increased fluorescence response of Case16 to low Ca2+ concentrations is that interactions between the CaM and the M13-peptide trigger chromophore conversion to the deprotonated high-fluorescent state. This hypothesis is in good agreement with conclusions from the Ca2+-saturated structure of GCaMP2 [15], which suggests that the key role of Ca2+-bound CaM is to reduce the solvent access to the chromophore. The structural changes that occur between the half Ca2+-saturated and Ca2+-saturated forms likely induce further changes in the chromophore environment that result in the fluorescent response to high Ca2+ concentrations. We believe that the obtained data can be extrapolated to all cpGFP-based FCIPs since they share high sequence homology (Supplementary Figure 1).
3.2. Chromophore Environment in Case16 Structure A
Case16 structure A demonstrates that Glu148 contacts the cpGFP chromophore directly (Figure 2), which is consistent with our previous conclusions based on site-specific mutagenesis [7]. Therefore it can influence significantly the fluorescent properties of the sensor. In contrast, Ser145 is located rather distant from the chromophore (Figure 2, Supplementary Figure 2), refuting our previous hypothesis that both residues (Ser145 and Glu148) are in direct contact with the chromophore [7]. The present results demonstrate that Ser145 is instead a part of the peptide linker joining cpGFP with CaM-domain. To confirm this we performed site-directed mutagenesis to generate the mutant variant Case16-Ser145Ala. In vitro tests demonstrated that Case16-Ser145Ala was also characterized by high-contrast Ca2+-dependent fluorescent response, (up to 10-fold increase of green fluorescence upon Ca2+-saturation) which is close to the response of Case12 (data not shown). These results indicate that the amino acid residue 145 does not contact cpGFP chromophore within cpGFP-based Ca2+ sensor constructs directly. This is consistent with the previously reported Ca2+-saturated structures of Ca2+ sensor GCaMP2, demonstrating that Thr145 is not in close proximity to the chromophore [14,15].
Also of note is that Tyr143 is the last residue of the sensor construct which keeps its original location in the β-barrel as compared to GFP, while the NSRDQL stretch acts as a linker between cpGFP and CaM-domains. The side chain of Tyr143 protrudes out of the beta-barrel and thus can not interact with the chromophore of cpGFP in this structure.
3.3. At high Concentrations Ca2+ Sensors Can form Non-Functional Homodimers in Presence of Saturating Ca2+ Concentrations
Crystallization condition B (see Experimental Section) was used to generate a Ca2+-saturated crystal of another high-contrast Ca2+ sensor variant, Case12 [7]. The 3D-structure of Case12 at high Ca2+ concentration (Case12 structure B) was refined to a 2.6 Å resolution (Table 1) and revealed that the binding mode of the M13-peptide to the CaM-domain was similar to the recently reported Ca2+-saturated dimeric crystal structures of GCaMP2 [14,15]. Case12 structure B is a dimer in the asymmetric unit where the M13-peptide is bound to the CaM-moiety of the neighboring molecule (Figure 3). In contrast to the Case16 structure A, both lobes of CaM are bound to M13-peptide of a neighboring sensor molecule. As was expected for the Ca2+-saturated form of the sensor, all four Ca2+-binding pockets of CaM are occupied by Ca2+ ions. The binding mode between CaM and the M13- peptide is similar to that reported in [26] (1CDL)). The alignment of both structures has an rmsd of 0.91 for the whole CaM-domain (127 Cα positions).
To estimate the rate of homodimerization of Case12 and Case16 we performed in vitro measurements using static multi-angle light scattering in conjunction with gel filtration at moderate and high sensor protein concentrations in the presence/absence of Ca2+ (Figure 4 and Table 2). For the first set of experiments we used Case12 and Case16 at a concentration of 4 mg/mL. At this concentration, in the presence of 1 mM Ca2+ or EGTA, both sensors were characterized by a homogeneous molecular mass of about 45 kDa, corresponding to the monomeric form. Similar results were obtained for Case12 and Case16 at high concentration (16 mg/mL) in presence of EGTA. In contrast, at high concentration (16 mg/mL) in presence of 1 mM Ca2+ a second distinct molecular mass of about 90 kDa was observed indicating dimerization for both sensors. These light-scattering experiments demonstrate that in the presence of Ca2+ Case12 and Case16 can form dimers at high sensor protein concentrations (Figure 4 and Table 2).
Table 2.
Sensor protein concentration | Ca2+ concentration | Case12 | Case16 |
---|---|---|---|
4 mg/mL | 1 mM | 3% dimer | 2% dimer |
4 mg/mL | 0 mM (5 mM EGTA) | 0% dimer | 0% dimer |
16 mg/mL | 1 mM | 22% dimer | 26% dimer |
16 mg/mL | 0 mM (5 mM EGTA) | 0% dimer | 0% dimer |
Case12 and Case16 did not show any dimerization taken at 4 mg/mL or 16 mg/mL in the absence of Ca2+. However both indicators tend to dimerize at concentration of 16 mg/mL in presence of 1 mM Ca2+. At concentration of 4 mg/mL both sensors formed only low rate of the dimeric form in presence of 1 mM Ca2+.
Importantly the maximum fluorescent response of Case12 and Case16 in vitro does not require high concentrations of the sensor (to test the Ca2+ response in vitro we usually use sensor protein concentrations 0.01–0.1 mg/mL) while dimerization only becomes significant at much higher protein concentrations (16 mg/mL). Therefore the detected fluorescent response of the sensor within the whole range of the monitored Ca2+ concentrations is induced by its monomeric form rather than its homodimer. The obtained Case12 structure B most probably resembles the non-functional homodimer and should not be interpreted as an example of the active Ca2+-saturated state of the sensor. Similar data were reported earlier for GCaMP2 Ca2+-saturated dimeric form [14,15].
In general, high expression levels of FCIPs are desirable for monitoring of Ca2+ changes in vivo. It should be noted that initial attempts to generate functional transgenic mouse lines with constitutive expression of FCIPs were largely unsuccessful. The possible explanation is that at low expression levels typically achieved in transgenic mice (40–190 nM) a substantial fraction of the genetically encoded sensor becomes immobilized and unresponsive. Such low FCIP expression levels were insufficient to monitor single-cell activity and to perform single-spike detection in neurons [27]. High levels of expression are often more easily attainable using virus-mediated gene transfer because of the presence of multiple copies of the viral genome. Recombinant adeno-associated virus (rAVV) gene transfer was used to drive robust (tens of μM) expression of an improved fluorescence resonance energy transfer-based FCIP D3cpv in neurons that allowed single-spike detection [28]. The rAVV expression system permits gene delivery in a wide range of animals and should be useful for targeting most neuronal cell types in the brain. For example, using rAAV delivery strategy of Case12 it was demonstrated that astroglia is the main cellular substrate of angiotensin-(1-7) action in rat rostral ventro-lateral medulla, indicating that high expression level of FCIP is crucial for its efficient functioning [29].
On the other hand, our data indicate that homodimer formation is favored at high concentrations of GCaMP-like sensors. Although such homodimerization is negligible at moderate sensor concentration (4 mg/mL or approximately 85 μM, which corresponds to the level of FCIP expression in neurons by means of rAVV delivery), it becomes significant at 4-fold higher concentration, that can be also potentially achieved locally in living cells at high expression levels, especially for the FCIP versions targeted to the specific cellular compartments. This effect should be taken into account for the future design of improved Ca2+ sensors.
3.4. The Dependence of Case12 and Case16 Fluorescent Response on High Concentrations of Free CaM or M13-Peptide
Apart from homodimer formation, CaM/M13-based FCIPs can also interact with free CaM and CaM-binding proteins that may interfere with their functions. In order to decrease interactions with putative intracellular targets, Palmer and coworkers successfully reengineered the binding interface of CaM and M13-peptide by computational design and generated a mutant CaM-M13 pair that was unaffected by large concentrations of excess CaM and was used to obtain improved FCIP variants [30]. However, no titration was performed using excess M13-peptide, thus it remained unclear whether this design also reduced the sensitivity to numerous CaM-binding partners.
We performed experiments where Case12 or Case16 were mixed with either free CaM or M13-peptide at various concentrations in order to check whether they may disrupt the intramolecular binding of M13-peptide to CaM within the sensor and thus decrease its dynamic range (for the experimental setup see Experimental Section). For the titration experiments, free M13-peptide and CaM were incubated with the sensor proteins at a final concentration of 5 μM (corresponding to 0.25 mg/mL). Purified Case12 and Case16 proteins were titrated in vitro with 5-fold molar excess of CaM or 20-fold molar excess of M13-peptide, respectively. Under our conditions CaM did not inhibit Ca2+-dependent fluorescent response of both sensor variants. In contrast, addition of M13-peptide significantly inhibited the sensor response even at low concentrations (Figure 5). Based on this data we hypothesize that interaction of the sensor construct with free M13-peptide is spatially and energetically more favorable than the intramolecular binding between M13-peptide and CaM. It remains unclear why the analogous effect was not observed with free CaM. A possible explanation is that the larger size and/or electrostatic repulsion of CaM in the sensor construct interferes with the binding of added CaM molecule to the M13-peptide of the sensor construct.
4. Conclusions
Using low Ca2+ concentration we were able to freeze the GCaMP-like Ca2+ sensor Case16 in its “half Ca2+-bound state” where only two C-terminal Ca2+-binding sites of CaM were occupied with Ca2+. Most likely this Case16 structure A corresponds to the first stage of the fluorescent response of the sensor at low Ca2+ concentrations. In contrast, the crystal structure of a closely related Ca2+ sensor Case12 (Case12 structure B) in presence of high Ca2+ concentrations shows that such sensors can dimerize. As shown in our light-scattering experiments, the formation of such a homodimer is favored at high sensor protein concentrations that could potentially be achieved locally in living cells with high sensor expression levels. We believe that the obtained data can be extrapolated to other cpGFP-based GCaMP-like Ca2+-sensors due to their high degree of homology (see Supplementary Figure 1 for a sequence alignment), and that our results will enable design of new genetically encoded FCIPs with improved characteristics.
Supplementary Data
Acknowledgments
We would like to thank Alain Dietrich and Markus Kroemer for their support in scientific computing. In addition, we would like to thank Ehmke Pohl and his team at PXII beam line at SLS in Villigen for maintaining an outstanding facility. We would like to acknowledge Christopher Farady for careful proof-reading and his comments to the manuscript. This work was supported by Molecular and Cell Biology Program RAS, Rosobrazovanie [P 256], RFBR [09-04-92603-КO_a; 10-04-01042; 08-04-01702-a].
References
- 1.Miyawaki A, Llopis J, Heim R, McCaffery JM, Adams JA, Ikura M, Tsien RY. Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. Nature. 1997;388:882–887. doi: 10.1038/42264. [DOI] [PubMed] [Google Scholar]
- 2.Baird GS, Zacharias DA, Tsien RY. Circular permutation and receptor insertion within green fluorescent proteins. Proc. Natl. Acad. Sci. USA. 1999;96:11241–11246. doi: 10.1073/pnas.96.20.11241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Nagai T, Yamada S, Tominaga T, Ichikawa M, Miyawaki A. Expanded dynamic range of fluorescent indicators for Ca2+ by circularly permuted yellow fluorescent proteins. Proc. Natl. Acad. Sci. USA. 2004;101:10554–10559. doi: 10.1073/pnas.0400417101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Nakai J, Ohkura M, Imoto K. A high signal-to-noise Ca2+ probe composed of a single green fluorescent protein. Nat. Biotechnol. 2001;19:137–141. doi: 10.1038/84397. [DOI] [PubMed] [Google Scholar]
- 5.Ohkura M, Matsuzaki M, Kasai H, Imoto K, Nakai J. Genetically encoded bright Ca2+ probe applicable for dynamic Ca2+ imaging of dendritic spines. Analyt. Chem. 2005;77:5861–5869. doi: 10.1021/ac0506837. [DOI] [PubMed] [Google Scholar]
- 6.Tallini YN, Ohkura M, Choi BR, Ji G, Imoto K, Doran R, Lee J, Plan P, Wilson J, Xin HB, Sanbe A, Gulick J, Mathai J, Robbins J, Salama G, Nakai J, Kotlikoff MI. Imaging cellular signals in the heart in vivo: Cardiac expression of the high-signal Ca2+ indicator GCaMP2. Proc. Natl. Acad. Sci. USA. 2006;103:4753–4758. doi: 10.1073/pnas.0509378103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Souslova EA, Belousov VV, Lock JG, Strömblad S, Kasparov S, Bolshakov AP, Pinelis VG, Labas YA, Lukyanov S, Mayr LM, Chudakov DM. Single fluorescent protein-based Ca2+ sensors with increased dynamic range. BMC Biotechnol. 2007:e7–37. doi: 10.1186/1472-6750-7-37. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Tian L, Hires SA, Mao T, Huber D, Chiappe ME, Chalasani SH, Petreanu L, Akerboom J, McKinney SA, Schreiter ER, Bargmann CI, Jayaraman V, Svoboda K, Looger LL. Imaging neural activity in worms, flies and mice with improved GCaMP calcium indicators. Nat. Methods. 2009;6:875–881. doi: 10.1038/nmeth.1398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Heim N, Griesbeck O. Genetically encoded indicators of cellular calcium dynamics based on troponin C and green fluorescent protein. J. Biol. Chem. 2004;279:14280–14286. doi: 10.1074/jbc.M312751200. [DOI] [PubMed] [Google Scholar]
- 10.Mank M, Reiff DF, Heim N, Friedrich MW, Borst A, Griesbeck O. A FRET-based calcium biosensor with fast signal kinetics and high fluorescence change. Biophys. J. 2006;90:1790–1796. doi: 10.1529/biophysj.105.073536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Mank M, Santos AF, Direnberger S, Mrsic-Flogel TD, Hofer SB, Stein V, Hendel T, Reiff DF, Levelt C, Borst A, Bonhoeffer T, Hübener M, Griesbeck O. A genetically encoded calcium indicator for chronic in vivo two-photon imaging. Nat. Methods. 2008;5:805–811. doi: 10.1038/nmeth.1243. [DOI] [PubMed] [Google Scholar]
- 12.Patterson GH, Lippincott-Schwartz J. A photoactivatable GFP for selective photolabeling of proteins and cells. Science. 2002;13:1873–1877. doi: 10.1126/science.1074952. [DOI] [PubMed] [Google Scholar]
- 13.Chudakov DM, Verkhusha VV, Staroverov DB, Souslova EA, Lukyanov S, Lukyanov KA. Photoswitchable cyan fluorescent protein for protein tracking. Nat. Biotechnol. 2004;22:1435–1439. doi: 10.1038/nbt1025. [DOI] [PubMed] [Google Scholar]
- 14.Wang Q, Shui B, Kotlikoff MI, Sondermann H. Structural basis for calcium sensing by GCaMP2. Structure. 2008;16:1817–1827. doi: 10.1016/j.str.2008.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Akerboom J, Rivera JD, Guilbe MM, Malavé EC, Hernandez HH, Tian L, Hires SA, Marvin JS, Looger LL, Schreiter ER. Crystal structures of the GCaMP calcium sensor reveal the mechanism of fluorescence signal change and aid rational design. J. Biol. Chem. 2009;284:6455–6464. doi: 10.1074/jbc.M807657200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Palmer AE, Giacomello M, Kortemme T, Hires SA, Lev-Ram V, Baker D, Tsien RY. Ca2+ indicators based on computationally redesigned calmodulin-peptide pairs. Chem. Biol. 2006;13:521–530. doi: 10.1016/j.chembiol.2006.03.007. [DOI] [PubMed] [Google Scholar]
- 17.Zeng G. Sticky-end PCR: new method for subcloning. Biotechniques. 1998;25:206–208. doi: 10.2144/98252bm05. [DOI] [PubMed] [Google Scholar]
- 18.Freuler F, Stettler T, Meyerhofer M, Leder L, Mayr LM. Development of a novel Gateway-based vector system for efficient, multiparallel protein expression in Escherichia coli. Protein Expr. Purif. 2008;59:232–241. doi: 10.1016/j.pep.2008.02.003. [DOI] [PubMed] [Google Scholar]
- 19.Kabsch W. Automatic indexing of rotation diffraction patterns. J. Appl. Crystallogr. 1988;21:67–71. [Google Scholar]
- 20.Kroemer M, Dreyer MK, Wendt KU. APRV—A program for automated data processing, refinement and visualization. Acta Crystallogr. D. Biol. Crystallogr. 2004;60:1679–1682. doi: 10.1107/S0907444904015215. [DOI] [PubMed] [Google Scholar]
- 21.Vagin AA, Teplyakov A. MOLREP: An automated program for molecular replacement. J. Appl. Crystallogr. 1997;30:1022–1025. [Google Scholar]
- 22.Emsley P, Cowtan K. COOT: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 2004;60:2126–2132. doi: 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]
- 23.Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D. Biol. Crystallogr. 1997;53:240–255. doi: 10.1107/S0907444996012255. [DOI] [PubMed] [Google Scholar]
- 24.Maune JF, Klee CB, Beckingham K. Ca2+ binding and conformational change in two series of point mutations to the individual Ca(2+)-binding sites of calmodulin. J. Biol. Chem. 1992;267:5286–5295. [PubMed] [Google Scholar]
- 25.Linse S, Helmersson A, Forsen S. Calcium binding to calmodulin and its globular domains. J. Biol. Chem. 1991;266:8050–8059. [PubMed] [Google Scholar]
- 26.Meador WE, Means AR, Quiocho FA. Target enzyme recognition by calmodulin: 2.4 Å structure of a calmodulin-complex. Science. 1992;257:1251–1255. doi: 10.1126/science.1519061. [DOI] [PubMed] [Google Scholar]
- 27.Hasan MT, Rainer WF, Euler T, Larkum ME, Giese G, Both M, Duebel J, Waters J, Bujard H, Griesbeck O, Tsien RY, Nagai T, Miyawaki A, Denk W. Functional fluorescent Ca2+ indicator proteins in transgenic mice under TET control. PLoS Biol. 2004;2:e163. doi: 10.1371/journal.pbio.0020163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Wallace DJ, Alten-Borghof SM, Astori S, Yang Y, Bausen M, Kugler S, Palmer AE, Tsien RY, Sprengel R, Kerr JND, Denk W, Hasan MT. Single-spike detection in vitro and in vivo with a genetic Ca2+ sensor. Nat. Methods. 2008;5:797–804. doi: 10.1038/nmeth.1242. [DOI] [PubMed] [Google Scholar]
- 29.Guo F, Liu B, Lane S, Souslova EA, Chudakov DM, Paton JFR, Kasparov S. Astroglia is a possible cellular substrate of angiotensin-II effects in the rostral ventro-lateral medulla. Cardiovasc Res. 2010 doi: 10.1093/cvr/cvq059. in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Palmer AE, Giacomello M, Kortemme T, Hires SA, Lev-Ram V, Baker D, Tsien RY. Ca2+ indicators based on computationally redesigned calmodulin-peptide pairs. Chem. Biol. 2006;13:521–530. doi: 10.1016/j.chembiol.2006.03.007. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.